(IN BRIEF) Novartis has finalized its US manufacturing and research expansion plan with the announcement of a seventh new facility in Morrisville, North Carolina, dedicated to producing active pharmaceutical ingredients for solid-dose medicines and RNA therapies. The move is part … Read the full press release
